Cape Verde vs Estonia: The number of people with susceptibility test result for rifampicin
Cape Verde
98
in 2021
Estonia
74
in 2021
Cape Verde rank
110th
Estonia rank
113th
The number of people with susceptibility test result for rifampicin over time
- Cape Verde
- Estonia
How they compare
Cape Verde currently reports 98 against 74 in Estonia, a difference of 24.
That makes Cape Verde's figure about 1.3 times Estonia's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Estonia ahead.
Cape Verde ranks 110th and Estonia ranks 113th of 155 countries.
Across the 2 decades both report, Cape Verde averaged higher in 1 and Estonia in 1.
Head to head by decade
| Decade | Cape Verde | Estonia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 82.33 | 111 | 28.67 | Estonia |
| 2020s | 87.5 | 82.5 | 5 | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cape Verde or Estonia?
- Cape Verde, at 98 against 74 in Estonia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cape Verde and Estonia?
- 24, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Estonia?
- 5 years are reported by both, from 2017 to 2021.
- How do Cape Verde and Estonia rank globally for the number of people with susceptibility test result for rifampicin?
- Cape Verde ranks 110th and Estonia ranks 113th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.